Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
The grey matter correlates of impaired decision-making in multiple sclerosis.
Mouse hepatitis virus infection upregulates genes involved in innate immune responses.
Gateway to wellness: an occupational therapy collaboration with the national multiple sclerosis society.
Mixed Panniculitis Secondary to Interferon Beta-1a Therapy in a Woman With Multiple Sclerosis.
Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
Evidence linking HHV-6 with multiple sclerosis: an update.
Unmet education, psychological and peer support needs of people with multiple sclerosis.
Fingolimod induces neurogenesis in adult mouse hippocampus and improves contextual fear memory.
Involvement and interplay of Parkin, PINK1 and DJ1 in neurodegenerative and neuroinflammatory disorders.
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice.
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Validation of a new quality of life scale related to multiple sclerosis and relapses.
Roles of the ubiquitin peptidase USP18 in multiple sclerosis and the response to interferon-β treatment.
Quantitative determination of regional lesion volume and distribution in children and adults with relapsing-remitting multiple sclerosis.
Cannabis-based medicines in multiple sclerosis--a review of clinical studies.
Advances in Antioxidative Therapy of Multiple Sclerosis.
Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.
Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurol
Perceived and actual arm performance in multiple sclerosis: relationship with clinical tests according to hand dominance.
Treatment of Multiple Sclerosis With Chinese Scalp Acupuncture.
Neuron-oligodendrocyte myelination co-culture derived from embryonic rat spinal cord and cerebral cortex.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
Pages
« first
‹ previous
…
217
218
219
220
221
222
223
224
225
…
next ›
last »